This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Emilie Madura: Innovator in Medical Therapy
Introduction
Emilie Madura is a prominent inventor based in Stevenage, GB. She has made significant contributions to the field of medical therapy through her innovative work. With a focus on binding proteins, her research has the potential to impact various medical treatments.
Latest Patents
Emilie holds a patent for "CR2 Binding Proteins and their use in Medical Therapy." This patent represents her dedication to advancing medical science and improving therapeutic options for patients. She has successfully secured 1 patent in her field.
Career Highlights
Emilie is currently employed at GlaxoSmithKline Intellectual Property Development Limited, where she continues to develop her ideas and contribute to the company's mission of enhancing healthcare solutions. Her work at this esteemed organization showcases her commitment to innovation in the pharmaceutical industry.
Collaborations
Emilie collaborates with Gerben Bouma, leveraging their combined expertise to drive forward their research initiatives. Their partnership exemplifies the importance of teamwork in achieving groundbreaking advancements in medical therapy.
Conclusion
Emilie Madura is a trailblazer in the field of medical therapy, with her innovative patent and collaborative efforts paving the way for future advancements. Her work at GlaxoSmithKline highlights her dedication to improving healthcare through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile